NTRK2 and Cognitive impairment: Improvement in cognitive impairment; Improvement in synaptic ultrastructure; Cell proportions (BDNF↑, pCREB↑); Protein expression level (PSD-95↑, pTrkB/TrkB ratio↑); mRNA expression (BDNF↓, TrkB↓, CREB↓)